EKG — CardioComm Solutions Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for CardioComm Solutions, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.835	0.683	0.996	0.876	0.527
Cost of Revenue
Gross Profit	0.682	0.611	0.727	0.737	0.501
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Total Operating Expenses	0.98	0.948	1.07	1.12	0.856
Operating Profit	-0.146	-0.266	-0.079	-0.243	-0.33
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.064	0	-0.002	-0.097	-0.195
Net Income After Taxes	-0.064	0	-0.002	-0.097	-0.195
Net Income Before Extraordinary Items
Net Income	-0.064	0	-0.002	-0.097	-0.195
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.064	0	-0.002	-0.097	-0.195
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0	0	-0	-0.001	-0.001